Patchy deletion of Bmpr1a potentiates proximal pulmonary artery remodeling in mice exposed to chronic hypoxia
- PMID: 22314711
- PMCID: PMC3505237
- DOI: 10.1007/s10237-012-0379-6
Patchy deletion of Bmpr1a potentiates proximal pulmonary artery remodeling in mice exposed to chronic hypoxia
Abstract
Reduced vascular expression of bone morphogenetic protein type IA receptor (Bmpr1a) has been found in patients with pulmonary arterial hypertension. Our previous studies in mice with patchy deletion of Bmpr1a in vascular smooth muscle cells and cardiac myocytes showed decreased distal vascular remodeling despite a similar severity of hypoxic pulmonary hypertension (HPH). We speculate increased stiffness from ectopic deposition of collagen in proximal pulmonary arteries might account for HPH. Pulsatile pressure-flow relationships were measured in isolated, ventilated, perfused lungs of SM22α;TRE-Cre;R26R;Bmpr1a(flox/flox) (KO) mice and wild-type littermates, following 21 days (hypoxia) and 0 days (control) of chronic hypoxia. Pulmonary vascular impedance, which yields insight into proximal and distal arterial remodeling, was calculated. Reduced Bmpr1a expression had no effect on input impedance Z(0) (P = 0.52) or characteristic impedance Z(C) (P = 0.18) under control conditions; it also had no effect on the decrease in Z(0) via acute rho kinase inhibition. However, following chronic hypoxia, reduced Bmpr1a expression increased Z(C) (P < 0.001) without affecting Z(0) (P = 0.72). These results demonstrate that Bmpr1a deficiency does not significantly alter the hemodynamic function of the distal vasculature or its response to chronic hypoxia but larger, more proximal arteries are affected. In particular, reduced Bmpr1a expression likely decreased dilatation and increased stiffening in response to hypoxia, probably by collagen accumulation. Increased PA stiffness can have a significant impact on right ventricular function. This study illustrates for the first time how proximal pulmonary artery changes in the absence of distal pulmonary artery changes contribute to pulmonary arterial hypertension.
Figures




Similar articles
-
Smooth muscle protein 22alpha-mediated patchy deletion of Bmpr1a impairs cardiac contractility but protects against pulmonary vascular remodeling.Circ Res. 2008 Feb 15;102(3):380-8. doi: 10.1161/CIRCRESAHA.107.161059. Epub 2007 Dec 13. Circ Res. 2008. PMID: 18079409 Free PMC article.
-
Effects of acute Rho kinase inhibition on chronic hypoxia-induced changes in proximal and distal pulmonary arterial structure and function.J Appl Physiol (1985). 2011 Jan;110(1):188-98. doi: 10.1152/japplphysiol.00533.2010. Epub 2010 Nov 18. J Appl Physiol (1985). 2011. PMID: 21088209 Free PMC article.
-
SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis.Development. 2008 Sep;135(17):2981-91. doi: 10.1242/dev.017863. Epub 2008 Jul 30. Development. 2008. PMID: 18667463 Free PMC article.
-
Pulmonary vascular collagen content, not cross-linking, contributes to right ventricular pulsatile afterload and overload in early pulmonary hypertension.J Appl Physiol (1985). 2017 Feb 1;122(2):253-263. doi: 10.1152/japplphysiol.00325.2016. Epub 2016 Nov 17. J Appl Physiol (1985). 2017. PMID: 27856711 Free PMC article.
-
The role of collagen in extralobar pulmonary artery stiffening in response to hypoxia-induced pulmonary hypertension.Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1823-31. doi: 10.1152/ajpheart.00493.2009. Epub 2010 Sep 17. Am J Physiol Heart Circ Physiol. 2010. PMID: 20852040 Free PMC article.
Cited by
-
Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target.Front Cardiovasc Med. 2021 Apr 12;8:649512. doi: 10.3389/fcvm.2021.649512. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 33912600 Free PMC article. Review.
-
BMP4 enhances foam cell formation by BMPR-2/Smad1/5/8 signaling.Int J Mol Sci. 2014 Mar 31;15(4):5536-52. doi: 10.3390/ijms15045536. Int J Mol Sci. 2014. PMID: 24690996 Free PMC article.
-
Targeting BMP signalling in cardiovascular disease and anaemia.Nat Rev Cardiol. 2016 Feb;13(2):106-20. doi: 10.1038/nrcardio.2015.156. Epub 2015 Oct 13. Nat Rev Cardiol. 2016. PMID: 26461965 Free PMC article. Review.
-
Insights into bone morphogenetic proteins in cardiovascular diseases.Front Pharmacol. 2023 Feb 23;14:1125642. doi: 10.3389/fphar.2023.1125642. eCollection 2023. Front Pharmacol. 2023. PMID: 36909186 Free PMC article. Review.
-
'There and Back Again'-Forward Genetics and Reverse Phenotyping in Pulmonary Arterial Hypertension.Genes (Basel). 2020 Nov 26;11(12):1408. doi: 10.3390/genes11121408. Genes (Basel). 2020. PMID: 33256119 Free PMC article. Review.
References
-
- Atkinson C, Stewart S, Upton PD, Machado R, Thomson JR, Trembath RC, Morrell NW. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation. 2002;105(14):1672–1678. - PubMed
-
- Bellusci S, Henderson R, Winnier G, Oikawa T, Hogan BL. Evidence from normal expression and targeted misexpression that bone morphogenetic protein (Bmp-4) plays a role in mouse embryonic lung morphogenesis. Development. 1996;122(6):1693–1702. - PubMed
-
- Benumof J. One-lung ventilation and hypoxic pulmonary vasoconstriction: implications for anesthetic management. Anesth Analg. 1985;64(8):821–833. - PubMed
-
- Cardoso WV. Molecular regulation of lung development. Annu Rev Physiol. 2001;63:471–494. - PubMed
-
- Du L, Sullivan CC, Chu D, Cho AJ, Kido M, Wolf PL, Yuan JX, Deutsch R, Jamieson SW, Thistlethwaite PA. Signaling molecules in nonfamilial pulmonary hypertension. N Engl J Med. 2003;348(6):500–509. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials